Mixed Connective Tissue Disease
📧 Sign up to get email alerts when something new happens for Mixed Connective Tissue Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
This completed University of Miami study examined characteristics and disease progression in patients with mixed connective tissue disease a…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intralesional Injection of STS in Treatment of Calcinosis [Phase 2]
A Phase 2 clinical trial evaluating intralesional sodium thiosulfate for calcinosis associated with systemic sclerosis and other connective …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
This clinical trial update notes that the study evaluating gynecological follow-up in patients with autoimmune diseases and inflammatory rhe…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD) [Phase 2]
Phase 2 study evaluating the safety, tolerability and efficacy of MHV370 in Sjögren's syndrome and mixed connective tissue disease was termi…
-
CLINICAL_TRIALS trial_result · 2021-10-07Clinical Trial Update: Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing rituximab to cyclophosphamide in connective tissue disease–associated interstitial lung disease has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases [Phase 4]
Phase 4 study assessing the safety and efficacy of an H1N1 vaccine in patients with rheumatic diseases. The current status of the trial is u…